Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials

Overview of attention for article published in Nature Medicine, June 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 50 news outlets
blogs: 7 blogs
twitter: 117 X users

facebook: 3 Facebook pages
wikipedia: 1 Wikipedia page
reddit: 3 Redditors

Readers on

mendeley: 109 Mendeley

So far, Altmetric has seen 127 X posts from 117 X users, with an upper bound of 4,090,831 followers.

@dynaglidecustom Hmm, c'est vite oublier les études de l'INSERM pour développer un vaccin contre l'addiction au cannabis 😉 https://t.co/hhM3y6ceNf

@SuonhoG @PagellaPolitica Basta leggere bene eh... Agevolo: https://t.co/OhzOtVxMqY https://t.co/OUcPxF98V0 https://t.co/6DAI09gW9u https://t.co/zhtit9lUdS https://t.co/GKtC9ILYi8

@rasNobu420 https://t.co/GWXj3kyLD4

There is more to it: the COVID–CB2 receptor connection. "[W]e found that β-caryophyllene and pregnenolone have a significant synergistic effect in the resolution of LPS-induced sepsis and inflammation in mice." https://t.co/dicBom6YPQ

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 123 additional X posts.